Evidence map›Paper›PMID 41631006›Full record

ArticlePhysics and imaging in radiation oncology2026

Tumor-conditioned inter-patient registration using planning computed tomography for voxel-based analysis to predict radiation pneumonitis in lung cancer patients.

Chloe Min Seo Choi, Jue Jiang, Nikhil P Mankuzhy, Nishant Nadkarni, Sudharsan Madhavan, Abraham J Wu, Joseph O Deasy, Maria Thor, Andreas Rimner, Harini Veeraraghavan

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chloe Min Seo ChoiDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States.
Jue JiangDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States.
Nikhil P MankuzhyDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, United States.
Nishant NadkarniDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States.
Sudharsan MadhavanDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States.
Abraham J WuDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, United States.
Joseph O DeasyDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States.
Maria ThorDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States.
Andreas RimnerDepartment of Radiation Oncology, University of Freiburg, Freiburg, Germany.
Harini VeeraraghavanDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Background and purpose: Deformable image registration (DIR) for voxel-based analysis (VBA) can be challenging in patients with non-small cell lung cancer (NSCLC) due to large variations in tumor size and location. This study aimed to assess whether a tumor-preserving inter-patient DIR approach improves VBA-based prediction of radiation pneumonitis (RP). Methods and materials: Three DIR methods were evaluated: deep learning-based Tumor-Aware Recurrent Registration (TRACER) and Patient-Specific Context and Shape (PACS), trained on a public dataset of 268 locally-advanced (LA) NSCLC patients, and iterative Symmetric Normalization (SyN). All methods were tested on 240 patients with LA-NSCLC. Geometric, dosimetric, and tumor preservation metrics were compared using the Wilcoxon signed-rank test. VBA was conducted with each DIR method to identify cohort-relevant regions (CRRs). Machine learning models incorporating clinical, dosimetric, and CRR dose features were used to predict grade 2 or higher RP. Results: TRACER best preserved tumor volume (1.39 %) and organ doses (mean 0.08 Gy) compared with PACS and SyN (p < 0.001). PACS showed higher geometric but worse dose preservation accuracy than TRACER. All DIR-based VBA methods identified the right lung as the CRR associated with RP. TRACER-derived CRR had slightly higher RP predictive performance (AUC 0.78 vs PACS 0.73 vs SyN 0.71), and outperformed the MLD-based ML model (AUC = 0.78 vs 0.69, p = 0.04; specificity = 0.62 vs 0.48). Conclusions: TRACER improved registration accuracy, with better tumor volume preservation and reduced OAR dose impact. Incorporating VBA-derived dose enhanced RP prediction accuracy compared with using MLD. CRRs identified through VBA were robust to the choice of DIR.

Indexed as

Deep learningInter-patient registrationLung cancerRadiation pneumonitis predictionVoxel-based analysis

Identifiers

PMID41631006
PMCPMC12861147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.